Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

Introduction A major driver of the global autologous cell therapy market is the rising demand for personalized and precision-based medical trea ...

Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...

intmed1.med.kyushu-u.ac.jp Objectives: To carry out a phase I-II trial to elucidate the feasibility and efficacy of high dose cyclophosphamide (CY) supported by autologous peripheral blood stem cell ...

Renal failure in multiple myeloma typically occurs when the kidneys fail to filter waste products from the blood, leading to ...

"This is the first study that utilized [chimeric antigen receptor (CAR] T cells in the BMT CTN," Garfall, director of Autologous Hematopoietic Stem Cell Transplantation, the section chief of Myeloma ...

Allogeneic hematopoietic stem cell transplantation (allo ... the importance of proactive, post-transplant immunomodulatory strategies to bridge the gap until novel therapies become available. This ...

Autologous hematopoietic stem cell transplantation (AHSCT) is an effective treatment for relapsingremitting multiple sclerosis, yet the mechanisms underlying immune reset and sustained remission ...

We report the results of autologous CD133+ stem cell implantation in nine cases of critical limb ischemia being considered for amputation. As PAD occurs in an elderly patient population with high ...